Since semaphorins are expressed by breast cancer cell lines including MDA-MB-231, or present in the breast cancer micro-environment in situ (Christensen et al, 2005), we suggest that our in vitro findings of NRP action are of in vivo relevance. Here, NRP1 is linked to breast cancer.